Skip to main content Accessibility help
×
Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-23T02:38:04.919Z Has data issue: false hasContentIssue false

21 - The economic impact of treatment non-response in major depressive disorders

from Part V - Economic and ethical issues

Published online by Cambridge University Press:  25 March 2010

Jay D. Amsterdam
Affiliation:
University of Pennsylvania
Mady Hornig
Affiliation:
University of California, Irvine
Andrew A. Nierenberg
Affiliation:
Harvard Medical School
Get access

Summary

Introduction

Major depressive disorders (MDD) impose a heavy toll on the US economy. Greenberg et al. (1993) estimate the economic burden of depression in 1990 at $44 billion due to the direct health care costs to treat depression ($12.4 billion), mortality cost due to suicide ($7.5 billion), and morbidity costs due to increased absenteeism and reduced productivity at work ($23.8 billion). Specific data on the components of aggregate costs are also available in the literature: reduced work place productivity and disability (Mintz, et al., 1992; Conti & Burton, 1994; Von Korff, et al., 1992; Broadhead, et al., 1990); increased mortality due to suicides (Barraclough, et al., 1974: Brent et al., 1988); and direct medical care costs (Wells et al., 1989; Katon & Sullivan, 1990).

Aggregate cost-of-illness data are an important first step in guiding society in determining how best to allocate scarce health-care resources between competing needs. Depression is an disorder which requires the attention of the US health-care system based on the data quoted above. However, much more detailed data are required to justify the allocation of additional resources to the treatment of depression. Specifically, data are needed on the frequency of, and cost associated with, suboptimal treatment outcomes. This is the focus of this chapter. Other chapters in this text present data on the effectiveness of alternative strategies for the re-treatment of patients who fail to respond to their initial course of therapy. If non-response to available therapies is found to be common and costly, then the deployment of alternative strategies for treating treatment-resistant depression may be economically justified.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2001

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×